Mirae Asset Global Etfs Holdings Ltd. Acrivon Therapeutics, Inc. Transaction History

Mirae Asset Global Etfs Holdings Ltd.

  • $43.4 Billion
  • Q1 2025

A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Acrivon Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 7,087 shares of ACRV stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,087
Previous 6,775 4.61%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
BUY
N/A
312 Added 4.61%
7,087 $0
Q4 2024

Feb 14, 2025
BUY
N/A
304 Added 4.7%
6,775 $0
Q3 2024

Nov 14, 2024
SELL
N/A
-37 Reduced 0.57%
6,471 $0
Q2 2024

Aug 14, 2024
BUY
N/A
6,508 New
6,508 $0

Others Institutions Holding ACRV

# of Institutions
61
Shares Held
22.6M
Call Options Held
0
Put Options Held
0
View Full List

About Acrivon Therapeutics, Inc.

ACRV Quotes by TradingView
  • Ticker ACRV
More about ACRV
Track This Portfolio

Track Mirae Asset Global Etfs Holdings Ltd. Portfolio

Follow Mirae Asset Global Etfs Holdings Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Etfs Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Etfs Holdings Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email